Overview

A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study will be to evaluate the safety and treatment response of paliperidone palmitate administered to Chinese patients with schizophrenia.
Phase:
Phase 4
Details
Lead Sponsor:
Xian-Janssen Pharmaceutical Ltd.
Treatments:
Paliperidone Palmitate